Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Solana stablecoin holders hit 14M as SOL falls 13% – Can adoption drive SOL?

Solana stablecoin holders hit 14M as SOL falls 13% – Can adoption drive SOL?

AMBCryptoAMBCrypto2026/10/26 00:03
By:AMBCrypto

Solana’s stablecoin usage is broadening, as evidenced by the increase of holder address accounts from less than 4 million in October 2024 to 14 million in October.

Due to this expansion, there is a greater number of holders who are now exposed to dollar-pegged assets, potentially making stablecoins more accessible for payments, trading, and DeFi activity.

As a result of the expanded interest in using Solana [SOL] stablecoins, the acceleration of new holders increased in 2025 and gained further momentum in 2026, pushing holder counts above 10 million.

@media only screen and (min-width: 0px) and (min-height: 0px) { div[id^="bsa-zone_1774359638628-7_123456"] { min-height: 50px; transition: min-height 0.3s ease; } } @media only screen and (min-width: 640px) and (min-height: 0px) { div[id^="bsa-zone_1774359638628-7_123456"] { min-height: 90px; } }
AD

Source: Blockworks

The total stablecoin supply on Solana is still in excess of $15 billion. This continued high level of supply provides liquidity to all aspects of the Solana ecosystem.

Meanwhile, more holders do not automatically equate to more active users or higher transaction counts. Ultimately, the impact of this growth will be measured by whether holders use these assets regularly, turning wider access into sustained network demand and deeper liquidity.

Stablecoin flows remain mixed

While Solana’s native on-chain stablecoin supply has expanded to over $15 billion, broader crypto market dynamics show a lack of new capital entering trading venues.

Beginning in June 2025, there have been multiple instances of large surges in both deposit and withdrawal amounts of stablecoins. This reflects changes in investor preferences and trading activity.

Additionally, peak inflow levels reached approximately $2.8 billion. This could provide additional liquidity to exchanges to facilitate buying.

Source: CryptoQuant

However, subsequent withdrawals have consistently reversed any potential gains. For instance,  in April there were withdrawals totaling approximately $2.3 billion. This pattern illustrates that investors have yet to establish a steady stream of capital flowing into exchanges.

More recently, netflows have approached neutral territory, with the latest reading at -$8.2 million. Without sustained inflows, immediate buying pressure may remain limited.

Stablecoin growth fails to lift SOL

Although exchange flows illustrate how liquidity moves within the Solana ecosystem, the overall performance of the SOL token represents whether the established capital base supports additional network-wide activity.

Despite its stablecoin supply sitting near $15.65 billion, SOL has traded at around $101-$102 since losing nearly 13% over the past 30 days. Similarly, weekly DEX volume has decreased approximately 9%.

This illustrates that despite having significant liquidity available, trading volume within the Solana DEX space has actually decreased.

Furthermore, DeFi TVL currently sits at $5.77 billion, and daily network fees continue to be around $477k. Both metrics indicate a gap exists between capital availability and actual economic activity occurring on the Solana network.

Source: DeFiLlama

Therefore, unless trading volumes, DeFi engagement, and fee generation trends begin to improve, the expanding stablecoin base may struggle to support a sustained SOL price recovery.

Final Summary

  • Solana stablecoin holders reached 14 million addresses in October 2026, while supply remained above $15 billion.

  • SOL fell over 13% in 30 days as DEX volume declined 9%, despite $15.65 billion in stablecoin supply.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion

The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.

华尔街见闻•2026/11/06 13:42
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion

Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight

Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.

华尔街见闻•2026/11/06 13:23

Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market

Eli Lilly is collaborating with Hims & Hers Health, leveraging the telehealth company’s large customer base to expand access to its blockbuster weight loss drugs and boost sales of medications, including its new oral weight loss drug Foundayo.

智通财经•2026/11/06 12:37
Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market